Efficacy of Educational Intervention for Parents of Children With Asthma

Universidad Autonoma de San Luis Potosí

Status

Completed

Conditions

Asthma

Treatments

Other: Educational intervention for parents

Study type

Interventional

Funder types

Other

Identifiers

NCT01979224

A-001

UASLP-001 (Registry Identifier)

Details and patient eligibility

About

Introduction. Asthma is a chronic inflammatory disorder of the airways, identified by airflow obstruction. Unfortunately only 2.4% of American asthmatics meet internationally recommended criteria for control. The lack of knowledge in parents of asthmatic children has been a direct result of minimum or no control at all, so the educational programs need to be assessed in terms of improvement of the control. Target. To determine whether an educational intervention aimed at parents of asthmatic children 4 to 11 years improved clinical control measured by Test Childhood Asthma Control. Material and Methods. Randomized controlled clinical trial in 42 patients randomly divided into two groups that were evaluated in the same time knowledge and control of asthma, a measurement was performed at baseline and monthly for nine months. The experimental group attended an educational intervention for individual reinforcements through this period, the control group was only monitored

Full description

Recruitment of patients that attended hospital's emergency gate due to asthma issues, and phone calls to regular physicians patients.
Once recruited all parents of patients were asked to participate in the study where their children will be evaluated on an asthma control and asked informed consent
The clinical history, spirometry and / or basal peak flow Diagnostic concordance
With the collected data was performed a database clinical history, ACT score, FEV1 and PEF, results of each patient and personal data for future location, the base was used for the concordance of diagnosis.
Once the sample that met the selection criteria were formed experimental and control groups at random using "R Project Statistical Computing" 2.12.2 version performed by the statistical
The experimental group was invited to participate in educational sessions two hours at week in just one month and monthly individual reinforcements through the evaluation period.
Educational sessions were based on the Global Initiative for Asthma (GINA), Guía Española para el Manejo del Asma (GEMA) And Concenso Mexicano de Asma.
Those measurements were performed by an external partner or educators or the attending physician performed to avoid biased results.

The monthly ACT and peak flow of the attending physician were blinded

variables:

educational intervention, with and without intervention
asthma control: measured by infant ACT
time: 0 to 9 months
sex: female or male
Age: 4 to 11 years

Enrollment

42 patients

Sex

All

Ages

4 to 11 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Eligibility Criteria

Children 4-11 years with diagnosed asthma with parents attending the outpatient pediatric pneumology and pediatric emergency because of acute asthma in General Hospital de Soledad.
Patients with a baseline score less than 27 points in childhood ACT
Patients with Government Health Insurance. (to ensure access to medication and medical care)
Parents who can read and write
Parents willing and able to participate
Parents who do not belong or have been part of an educational program on asthma by asthma clinic.

Exclusion Criteria

Parents with children having other comorbidities that prevent or hinder proper control of asthma, such as Cerebral Palsy, (PCI) psychomotor retardation, psychiatric Sd. Down, congenital malformations, which alter the chest wall, obesity, nasal polyp.

Elimination criteria

Parents who fail to attend 50% of the sessions given (since it does not allow parents to acquire sufficient knowledge to significantly improve the control of asthma as GEMA educational guidance)
Patients and parents who decide not to continue in the project.
Patients who develop pulmonary comorbidities over a month of evolution and lung tissue affecting significantly, as syncytial respiratory virus, pneumonia, tuberculosis, and asthma control difficulties.
Patients who leave or do not take the prescribed treatment by physician for a month.